Hemogenyx Pharmaceuticals Plc

HEMO.L · LSE
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-£5-£3-£0-£2
Dep. & Amort.£0£0£0£0
Deferred Tax£0£0£0£1
Stock-Based Comp.£0£0£0£0
Change in WC£1£1£0-£1
Other Non-Cash£0£0-£2-£0
Operating Cash Flow-£4-£2-£0-£3
Investing Activities
PP&E Inv.-£0-£0£0-£0
Net Acquisitions£0£0£0£0
Inv. Purchases£0£0£0£0
Inv. Sales/Matur.£0£0£0£0
Other Inv. Act.£0-£0£0£0
Investing Cash Flow£0-£0£0-£0
Financing Activities
Debt Repay.-£0£0-£0£0
Stock Issued£2£1£3£1
Stock Repurch.£0£0£0£0
Dividends Paid£0£0£0£0
Other Fin. Act.£0-£0£0-£0
Financing Cash Flow£2£0£3£1
Forex Effect£2£0-£0£0
Net Chg. in Cash£0-£1£0-£2
Supplemental Information
Beg. Cash£0£2£1£3
End Cash£0£0£2£1
Free Cash Flow-£4-£2-£0-£3
Hemogenyx Pharmaceuticals Plc (HEMO.L) Financial Statements & Key Stats | AlphaPilot